ライフサイエンスコーパス: docosahexaenoic acid

1 rated fatty acids (eicosapentaenoic acid and docosahexaenoic acid).

2 ns D and E, eicosapentaenoic acid (EPA), and docosahexaenoic acid.

3 roduces phosphatidylcholine (PC) enriched in docosahexaenoic acid.

4 ith TLR1 was inhibited by the n-3 fatty acid docosahexaenoic acid.

5 acterial species known for its production of docosahexaenoic acid.

6 ibrotic effects of eicosapentaenoic acid and docosahexaenoic acid.

7 ed by first covalently linking cysteamine to docosahexaenoic acid.

8 rated acyl chains, including arachidonic and docosahexaenoic acid.

9 dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.

10 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid.

11 eciprocally higher levels of arachidonic and docosahexaenoic acids.

12 in children who were fed variable amounts of docosahexaenoic acid (0.32%, 0.64%, and 0.96% of total f

13 .58); methionine, 0.31 (95% CI: 0.03, 0.60); docosahexaenoic acid, 0.43 (95% CI: 0.13, 0.73); DMA, 0.

14 ell apoptosis, which was abrogated by 100 nm docosahexaenoic acid, 10 ng/ml pigment epithelium-derive

15 vel of the Maresin pathway marker 14-hydroxy-docosahexaenoic acid (14-HDHA) was lower in activated pe

16 ipoxygenase (hm12-LOX) gave 14-hydro(peroxy)-docosahexaenoic acid (14-HpDHA), as well as several dihy

17 ations of alpha-linolenic acid (18:3n-3) and docosahexaenoic acid (20:6n-3) increased by 9.4 and 1.9

18 of eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (22:6 n-3) has been associated with

19 e. eicosapentaenoic acid (20:5 n-3, EPA) and docosahexaenoic acid (22:6 n-3, DHA) has previously prov

20 atty acids: eicosapentaenoic acid (22:5) and docosahexaenoic acid (22:6).

21 ng-chain polyunsaturated fatty acids (PUFAs) docosahexaenoic acid (22:6n-3) and arachidonic acid (20:

22 The proportion of docosahexaenoic acid (22:6n-3) of the total phospholipid

23 ds, eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA).

24 18:3n-3; eicosapentaenoic acid, 20:5n-3; and docosahexaenoic acid, 22:6n-3) comprised primary analyse

25 0 g) and, whilst it contained more (P<0.001) docosahexaenoic acid (30.9 vs. 13.7 mg/100 g), this was

26 4), omega-3 LCPUFAs (eicosapentaenoic acid + docosahexaenoic acid [650 mg/350 mg]; n = 1069), or the

27 nhances EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) abundance in the skin, comprehensi

28 The SPM precursor docosahexaenoic acid accelerated resolution via increase

29 xplored.Intakes of eicosapentaenoic acid and docosahexaenoic acid achieved the benchmark of R(2) > 36

30 rotein metabolized eicosapentaenoic acid and docosahexaenoic acid (an important constituent of the re

31 chemistry, and precursor role of 13,14-epoxy-docosahexaenoic acid, an intermediate in MaR1 biosynthes

32 -glutathionyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid and 16-cysteinylglycinyl, 17-hydrox

33 a day providing a total daily dose of 800 mg docosahexaenoic acid and 225 mg eicosapentaenoic acid),

34 n total n-3 PUFA, docosapentaenoic acid, and docosahexaenoic acid and 5-y weight change were observed

35 athionyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid and 8-cysteinylglycinyl, 7,17-dihyd

36 ssigned to receive formula containing either docosahexaenoic acid and arachidonic acid or no LCPUFAs

37 eceive 1) iron plus placebo, 2) a mixture of docosahexaenoic acid and eicosapentaenoic acid (DHA/EPA)

38 Results obtained with docosahexaenoic acid and eicosapentaenoic acid show ther

39 The omega-3 (n-3) fatty acids docosahexaenoic acid and eicosapentaenoic acid, along wi

40 c, and carotenoids with omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid; group 1,

41 with a human milk fat analogue enriched with docosahexaenoic acid and stearidonic acid, and the antio

42 ated that the bioactive structures contained docosahexaenoic acid and sulfido-conjugate (SC) of trien

43 mong all men, those with the highest omega-3 docosahexaenoic acid and total marine fatty acid intakes

44 , 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid) and D2 (RvD2, 7S,16R,17S-trihydrox

45 mg of lutein, 1 mg of zeaxanthin, 100 mg of docosahexaenoic acid, and 30 mg of eicosapentaenoic acid

46 LC-PUFAs, particularly docosahexaenoic acid, and nonfried fish, but not shellfi

47 ses including cholesterol, arachidonic acid, docosahexaenoic acid, and triacylglyceride 52:3.

48 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid] and alpha-linolenic acid) and n-6

49 minerals, fruit polyphenolics, beta-glucan, docosahexaenoic acid) appropriate for deconstruction and

50 aturated FAs (PUFAs; eicosapentaenoic acid + docosahexaenoic acid, arachidonic acid) in hepatic total

51 x [erythrocyte eicosapentaenoic acid (EPA) + docosahexaenoic acid, as a percentage of total fatty aci

52 T1A8 increased after treatment of cells with docosahexaenoic acid, as did UGT1A protein levels.

53 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid, because of the strength of evidenc

54 Eicosapentaenoic acid and docosahexaenoic acid blocked phospho-Smad2/3 nuclear tra

55 ved from omega-3 polyunsaturated fatty acid (docosahexaenoic acid), blocks TNF-alpha- and capsaicin-e

56 Eicosapentaenoic and docosahexaenoic acid blood levels were significantly hig

57 ecialized proresolving mediator derived from docosahexaenoic acid, but the mechanism is not known.

58 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid) by LTC4S and GSTM4.

59 han in the muscle, whereas the proportion of docosahexaenoic acid (C22:6 n-3) was higher in the muscl

60 urated fatty acids eicosapentaenoic acid and docosahexaenoic acid, can exert beneficial effects in in

61 -9 rich), 2) high-oleic acid canola oil with docosahexaenoic acid (CanolaDHA; n-9 and n-3 rich), 3) a

62 tty acids (PUFAs), eicosapentaenoic acid and docosahexaenoic acid, changing significantly over the du

63 onal nutrients, such as the eicosapentaenoic-docosahexaenoic acid combination and percentages of poly

64 Across model systems, docosahexaenoic acid-containing lipids enhance the stabi

65 ixth week of lactation, both arachidonic and docosahexaenoic acids correlated significantly inversely

66 n this study, we investigated the effects of docosahexaenoic acid-derived lipid mediator maresin 1 (M

67 Herein, we found that the docosahexaenoic acid-derived mediator resolvin D3 (RvD3)

68 d 5S-hydroxyeicosatetraenoic acid; decreased docosahexaenoic acid-derived neuroprotectin D1/protectin

69 cid eicosapentaenoic acid-derived resolvins, docosahexaenoic acid-derived resolvins, protectins, and

70 cosapentaenoic acid (DPA) (22:5omega-3), and docosahexaenoic acid (DHA) (22:6omega-3), have been show

71 s of rs174448 tended to associate with lower docosahexaenoic acid (DHA) (P = 0.052).

72 Oral docosahexaenoic acid (DHA) + aspirin therapy has been sh

73 show that an acute intravenous injection of docosahexaenoic acid (DHA) 30 min after spinal cord inju

74 Docosahexaenoic acid (DHA) accumulates in the hippocampu

75 saturates, CAL-A was used to concentrate 82% docosahexaenoic acid (DHA) and 11% omega-6 docosapentaen

76 nic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA) wer

77 Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

78 for Thermomyces lanuginosus lipase, so that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

79 ) usually are studied using a combination of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

80 from the omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

81 ossibly due to low levels of n-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

82 -3 endocannabinoid epoxides are derived from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

83 The long-chain omega-3 fatty acids (n-3 FAs) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EP

84 Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving

85 acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) and insulin resistance.

86 f hydroxy fatty acids-lipokines derived from docosahexaenoic acid (DHA) and linoleic acid, which were

87 nversion of 18:2n-6 to 20:4n-6 or 18:3n-3 to docosahexaenoic acid (DHA) and little evidence of mammar

88 ntal to nervous system construction, such as docosahexaenoic acid (DHA) and phosphatidylserines, appe

89 D-series resolvins are generated from docosahexaenoic acid (DHA) and promote macrophage-mediat

90 ed by PPL while eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and stearidonic acid (STA) we

91 n intakes of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the intermediate and adva

92 Comparison of the MS/MS spectra of docosahexaenoic acid (DHA) and universally (13)C-labeled

93 ga-3 [3.0 g eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) at a 5:1 ratio (EPA:DHA)] or

94 Several studies have shown that docosahexaenoic acid (DHA) attenuates epileptic seizures

95 ures of AA, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) bound to Co(3+)-protoporphyri

96 e hypothesis that 600 mg/d of the n-3 LCPUFA docosahexaenoic acid (DHA) can increase maternal and new

97 olving lipid mediators (SPMs) generated from docosahexaenoic acid (DHA) can modulate the vascular inj

98 The range of human milk docosahexaenoic acid (DHA) concentrations worldwide is m

99 ic acid (EPA) content remained unchanged and docosahexaenoic acid (DHA) content changed slightly.

100 Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in oil from spines, h

101 analyzed for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content, as well as for oxida

102 omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) found in oily fish lower bloo

103 Docosahexaenoic acid (DHA) has been demonstrated to poss

104 ary intake of the natural omega-3 fatty acid docosahexaenoic acid (DHA) has been implicated in protec

105 ng-chain polyunsaturated fatty acid (LCPUFA) docosahexaenoic acid (DHA) has proven effective at reduc

106 C n-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been demonstrated, and d

107 asurement of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in biological samples may pro

108 y effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans have used a mixture

109 ion, dose of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in omega-3 preparations, and

110 d the efficacy of post-TBI administration of docosahexaenoic acid (DHA) in reducing ER stress.

111 s showed that the levels of adrenic acid and docosahexaenoic acid (DHA) in testes were significantly

112 Docosahexaenoic acid (DHA) is a Delta4-desaturated C22 f

113 Docosahexaenoic acid (DHA) is an essential omega-3 fatty

114 Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated

115 e essential omega-3 fatty acid family member docosahexaenoic acid (DHA) is avidly retained and unique

116 Docosahexaenoic acid (DHA) is avidly retained in photore

117 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is currently limited because

118 ption factor PPARgamma by the n-3 fatty acid docosahexaenoic acid (DHA) is implicated in controlling

119 Docosahexaenoic acid (DHA) is important for brain functi

120 Docosahexaenoic acid (DHA) is increasingly considered fo

121 However, the anti-inflammatory mechanism of docosahexaenoic acid (DHA) is still not well understood.

122 Docosahexaenoic acid (DHA) is the most abundant long-cha

123 Docosahexaenoic acid (DHA) is uniquely concentrated in t

124 Docosahexaenoic acid (DHA) kinetics appear to change wit

125 d for salivary cortisol, whereas lower serum docosahexaenoic acid (DHA) levels were found in ADHD adu

126 generation indicates that 11-cis-retinal and docosahexaenoic acid (DHA) levels were significantly dec

127 obese and diabetic rodents is an increase in docosahexaenoic acid (DHA) levels.

128 y to restore eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels.

129 aR1) produced by human MPhis from endogenous docosahexaenoic acid (DHA) matched synthetic 7R,14S-dihy

130 rcury and the degree to which co-exposure to docosahexaenoic acid (DHA) may obscure these effects in

131 s issue) describe a novel mechanism by which docosahexaenoic acid (DHA) may suppress atopic dermatiti

132 the effect of prenatal supplementation with docosahexaenoic acid (DHA) on birth weight across select

133 llustrates the beneficial effects of dietary docosahexaenoic acid (DHA) on cardiovascular diseases.

134 um-derived factor (PEDF) in combination with docosahexaenoic acid (DHA) on corneal nerve regeneration

135 regnant women supplemented daily with 400 mg docosahexaenoic acid (DHA) or a placebo from 18 to 22 wk

136 al-derived factor (PEDF) in combination with docosahexaenoic acid (DHA) or vehicle for 6 weeks, and c

137 Docosahexaenoic acid (DHA) plays important physiological

138 ets of pregnant and lactating women [1020 mg docosahexaenoic acid (DHA) plus 180 mg eicosapentaenoic

139 e tested whether 15-18 months treatment with docosahexaenoic acid (DHA) plus eicosapentaenoic acid (E

140 Long-chain omega-3 fatty acids such as docosahexaenoic acid (DHA) reduce periodontitis in anima

141 Furthermore, the endogenous fatty acid docosahexaenoic acid (DHA) shows negative or neutral coo

142 Treatment of HREC with docosahexaenoic acid (DHA) specifically reduces expressi

143 Infant docosahexaenoic acid (DHA) status is supported by the DH

144 on4 (APOE4) allele are lower responders to a docosahexaenoic acid (DHA) supplement than are noncarrie

145 Eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) supplementation has beneficia

146 dence have contributed to the rationale that docosahexaenoic acid (DHA) supplementation of preterm in

147 Maternal docosahexaenoic acid (DHA) supplementation prevented the

148 iet intake, and subsequent modification with docosahexaenoic acid (DHA) supplementation.

149 ng PC and PE species, particularly ratios of docosahexaenoic acid (DHA) to arachidonic acid, were low

150 normal brain function, the pools that supply docosahexaenoic acid (DHA) to the brain are not agreed u

151 Higher maternal docosahexaenoic acid (DHA) was associated with improved

152 noleic acid (LA), arachidonic acid (AA), and docosahexaenoic acid (DHA) was developed using charge-sw

153 Circulating levels of docosahexaenoic acid (DHA) were also measured.

154 8-0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associ

155 ociations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with biomarkers of chronic di

156 ed n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with the risk of incident AF

157 d (e.g. palmitic acid) and unsaturated (e.g. docosahexaenoic acid (DHA)) LCFAs engage GPR120 and demo

158 We show here that the 15-LOX metabolites of docosahexaenoic acid (DHA), 17-hydroperoxy-, 17-hydroxy-

159 Docosahexaenoic acid (DHA), a dietary polyunsaturated fa

160 Here, we show that docosahexaenoic acid (DHA), a key omega-3 polyunsaturate

161 Docosahexaenoic acid (DHA), a polyunsaturated omega-3 fa

162 Topical application of docosahexaenoic acid (DHA), a representative omega-3 PUF

163 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), although originally synthesi

164 in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsatu

165 , higher plasma eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and total omega-3 (n-3) PUFA

166 he authors is to analyze the serum levels of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA),

167 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), elicit cardioprotective and

168 polyunsaturated omega-3 fatty acids such as docosahexaenoic acid (DHA), found abundantly in oily fis

169 (PUFAs), particularly the long-chain form of docosahexaenoic acid (DHA), has been linked to health pr

170 igment epithelium-derived factor (PEDF) plus docosahexaenoic acid (DHA), has been shown to stimulate

171 We report that the omega-3 fatty acid docosahexaenoic acid (DHA), in combination with bexarote

172 derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), little is known about the me

173 , especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may maintain cognitive funct

174 or source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), non-fish-eaters may have sub

175 cids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), not least of all given the i

176 ain n-3 (omega-3) polyunsaturated fatty acid docosahexaenoic acid (DHA), relative to the saturated fa

177 Docosahexaenoic acid (DHA), supplied by the diet or endo

178 from omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), termed resolvins.

179 [dietary fiber, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), vitamin C, and vitamin E] in

180 tors, such as those derived from the omega-3 docosahexaenoic acid (DHA), whose esterified form is tra

181 n in the United States do not consume enough docosahexaenoic acid (DHA)--an essential nutrient found

182 oic acid (EPA)-enriched n-3 1060 mg day(-1), docosahexaenoic acid (DHA)-enriched n-3 900 mg day(-1) o

183 is of polyunsaturated fatty acids, including docosahexaenoic acid (DHA).

184 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

185 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

186 ltransferase (PEMT) pathway is enriched with docosahexaenoic acid (DHA).

187 , especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

188 enoic acid (EPA), docosapentaenoic acid, and docosahexaenoic acid (DHA).

189 donic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).

190 acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).

191 n polyunsaturated fatty acids, in particular docosahexaenoic acid (DHA).

192 ern diet model in the absence or presence of docosahexaenoic acid (DHA).

193 were palmitic, oleic and cis-4,7,10,13,16,19-docosahexaenoic acid (DHA).

194 pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA).

195 O. tauri is known to efficiently produce docosahexaenoic acid (DHA).

196 mo of 3.9 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)/d (4.2 g total omega-3/d; n =

197 h is rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] affects insulin sensitivity

198 rated fatty acids [eicosapentaenoic acid and docosahexaenoic acid (DHA)] orchestrate resolution in di

199 tored liposomal and nanoliposomal systems of docosahexaenoic acid (DHA, 22:6 n-3) and eicosapentaenoi

200 Docosahexaenoic acid (DHA, 22:6 n-3) is abundant in the

201 chain n-3 (omega-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n-3) and eicosapentaenoic

202 Docosahexaenoic acid (DHA, 22:6n-3) is an essential comp

203 Docosahexaenoic acid (DHA, 22:6n-3) is an omega-3 fatty

204 hain polyunsaturated fatty acids (LC-PUFAs), docosahexaenoic acid (DHA, C22:6) and eicosapentaenoic a

205 The current study showed that docosahexaenoic acid (DHA, C22:6), eicosapentaenoic acid

206 This study investigated the impacts of docosahexaenoic acid (DHA, C22:6, n-3) and/or phosphatid

207 nthocyanidins extract (GSPE) and oil rich in docosahexaenoic acid (DHA-OR) on lipidic postprandial ox

208 have dramatically reduced concentrations of docosahexaenoic acid (DHA; 22:6n-3) in plasma and of liv

209 nce to support a negative association of low docosahexaenoic acid (DHA; 22:6n-3) with full-scale IQ (

210 tal development, the nervous system accretes docosahexaenoic acid (DHA; 22:6n-3), a highly unsaturate

211 via eicosapentaenoic acid (EPA; 20:5n-3) to docosahexaenoic acid (DHA; 22:6n-3), which is required f

212 eicosapentaenoic acid (EPA; 20:5omega-3) and docosahexaenoic acid (DHA; 22:6omega-3), from diet and s

213 Lipids extracted contained docosahexaenoic acid (DHA; C22:6(n-3)) as the most abund

214 eicosapentaenoic acid (EPA; C20:5(n-3)) and docosahexaenoic acid (DHA; C22:6(n-3)) were noticeable a

215 , such as arachidonic, eicosapentaenoic, and docosahexaenoic acids (DHA), can be acquired from the di

216 containing eicosapentaenoic (EPA, 20:5) and docosahexaenoic acids (DHA, 22:6).

217 ga-3 long-chain polyunsaturated fatty acids (docosahexaenoic acid [DHA] + eicosapentaenoic acid [EPA]

218 Omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EP

219 n of baseline levels of omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EP

220 80 mg eicosapentaenoic acid [EPA] and 120 mg docosahexaenoic acid [DHA]) daily for 30 days, and the p

221 ay eicosapentaenoic acid [EPA], + 510 mg/day docosahexaenoic acid [DHA]), or fish oil (1000 mg/day EP

222 ay eicosapentaenoic acid [EPA], + 510 mg/day docosahexaenoic acid [DHA]), or fish oil (1000 mg/day EP

223 ic acid, SA; eicosapentaenoic acid, EPA; and docosahexaenoic acid, DHA) were also prepared in the for

224 n oil; 15 VF+, 11 VF-) or n-3 PUFA (1-4 g/d, docosahexaenoic acid+eicosapentaenoic acid ethyl esters,

225 Docosahexaenoic acid, enriched in the brain and retina,

226 erent n-3 LC-PUFA levels in egg yolk, mainly docosahexaenoic acid enrichment.

227 vanillyl ester (DHA-VE) was synthesized from docosahexaenoic acid ethyl ester (DHA-EE) and vanillyl a

228 daily (840 mg eicosapentaenoic acid/2520 mg docosahexaenoic acid) for 6 months.

229 A (stearic acid) for the sn-1 chain and DHA (docosahexaenoic acid) for the sn-2 chain is representati

230 combined intake of eicosapentaenoic acid and docosahexaenoic acid from diet and supplements was assoc

231 rated fatty acids (eicosapentaenoic acid and docosahexaenoic acid) from fish oil ameliorate cardiovas

232 m of eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids) had significantly reduced endomet

233 mega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects in various

234 mega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects that may le

235 thesized from essential fatty acids, such as docosahexaenoic acid, have tissue protective effects in

236 cid (14-HpDHA), as well as several dihydroxy-docosahexaenoic acids, implicating an epoxide intermedia

237 d the link between fish consumption and high docosahexaenoic acid in breast milk and 2 studies that r

238 fatty acid analysis showed mild decrease in docosahexaenoic acid in the retina of the Rpgr-DKO mice

239 n between 18-carbon TFAs and arachidonic and docosahexaenoic acids in both artery and vein wall lipid

240 Eicosapentaenoic acid and docosahexaenoic acid increased cyclic GMP levels and blo

241 Eicosapentaenoic acid and docosahexaenoic acid increased phosphorylated endothelia

242 me P450 epoxygenases from omega-3 fatty acid docosahexaenoic acid, inhibit VEGF- and fibroblast growt

243 that the omega-3 polyunsaturated fatty acid docosahexaenoic acid is robustly incorporated into membr

244 atty acids (0.89; 0.84-0.94; P=6x10(-5)) and docosahexaenoic acid levels (0.90; 0.86-0.95; P=5x10(-5)

245 er circulating total long-chain n-3 PUFA and docosahexaenoic acid levels were associated with lower r

246 (eicosapentaenoic acid+docosapentaenoic acid+docosahexaenoic acid) levels was 0.71 (95% confidence in

247 This study determined that hydroxylated docosahexaenoic acid metabolites (HDoHEs) are substrates

248 arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid metabolomes.

249 id concentrations (eicosapentaenoic acid and docosahexaenoic acid) modify the treatment effect of hom

250 rage intakes of fish, eicosapentaenoic acid, docosahexaenoic acid, n-3 PUFAs, n-6 PUFAs, and the n-3:

251 plementation with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty acid

252 ega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid) on brain atrophy rates.

253 06), linolenic acid (p < 0.0001, p = 0.002), docosahexaenoic acid (p < 0.0001, p = 0.0024), eicosapen

254 es of phospholipid eicosapentaenoic acid and docosahexaenoic acid (P for trend = 0.05).

255 a specialized proresolving mediator from the docosahexaenoic acid pathway shifts the balance toward r

256 relatively innocuous omega-3 fatty acid DHA (docosahexaenoic acid), piracetam, quercetin, vitamin D a

257 7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid), potent anti-inflammatory and pror

258 tin D1/protectin D1 (NPD1/PD1), derived from docosahexaenoic acid, prevents nerve injury-induced mech

259 einylglycinyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid (Protectin sulfido-conjugates) or 8

260 cid, linoleic acid, alpha-linolenic acid and docosahexaenoic acid PUFAs are associated with AN diagno

261 fatty acids (2 g/day) (eicosapentaenoic acid:docosahexaenoic acid ratio 1:2), vitamin C (1 g/day), an

262 glycinyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid (Resolvin sulfido-conjugates).

263 ylated PGHS-2 from eicosapentaenoic acid and docosahexaenoic acid, respectively, so we also character

264 s, containing the polyunsaturated fatty acid docosahexaenoic acid, results in the accumulation of an

265 hat proved to be 13-glutathionyl, 14-hydroxy-docosahexaenoic acid (SCI) and 13-cysteinylglycinyl, 14-

266 d (SCI) and 13-cysteinylglycinyl, 14-hydroxy-docosahexaenoic acid (SCII).

267 Docosahexaenoic acid showed a greater inverse associatio

268 nonparametrically, both total n-3 PUFAs and docosahexaenoic acid showed graded and linear inverse as

269 Docosahexaenoic acid signaling was one of the top biolog

270 al stability, viscosity, relative content of docosahexaenoic acid, stearidonic acid and total oxidati

271 romal cells exposed to carbon monoxide, with docosahexaenoic acid substrate, produced specialized pro

272 mes more eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid than the fillets of wild fish.

273 Monkeys fed docosahexaenoic acid, the long-chain omega-3 fatty acid

274 olone sulfate, 24(S)-hydroxycholesterol, and docosahexaenoic acid, three endogenous modulators derive

275 t hereditary risk of allergic disease in the Docosahexaenoic Acid to Optimise Mother Infant Outcome r

276 erted 17-hydro(peroxy)-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid to these bioactive molecules.

277 nses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid

278 Arachidonic acid and docosahexaenoic acid, two final products of the enzyme,

279 Docosahexaenoic acid vanillyl ester (DHA-VE) was synthes

280 in an ongoing double-blind treatment trial (docosahexaenoic acid vs placebo; clinicaltrials.gov NCT0

281 Docosahexaenoic acid was converted by platelet 12-lipoxy

282 re reduced up to 98%, whereas the content of docosahexaenoic acid was diminished in TG, but not rod c

283 Docosahexaenoic acid was positively associated with high

284 teraction of Nur77 with arachidonic acid and docosahexaenoic acid was subsequently characterized usin

285 ake of individual eicosapentaenoic acids and docosahexaenoic acids was inversely related to distal la

286 capsules/day, 1080 mg eicosapentaenoic acid+docosahexaenoic acid) was associated with a 33.6% reduct

287 yl, 14S-hydroxy-4Z,7Z,9E,11E,13R,14S,16Z,19Z-docosahexaenoic acid) was catalyzed by gamma-glutamyl tr

288 4S-eMaR (13S,14S-epoxy- 4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid) was converted to MCTR1 (13R-glutat

289 vel of C24:6 n-3, the immediate precursor of docosahexaenoic acid, was decreased in cells expressing

290 sapentanoic acid, docosapentaenoic acid, and docosahexaenoic acid] was 1.18 (95% CI: 1.05, 1.34; P-tr

291 c acid, d(5)-eicosapentaenoic acid, and d(5)-docosahexaenoic acid), we found that apoptotic PMN and m

292 se blood levels of eicosapentaenoic acid and docosahexaenoic acid were in the lowest third of the tri

293 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were measured at baseline by use of

294 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were observed.

295 , quartiles 4 versus 1 eicosapentaenoic plus docosahexaenoic acids were suggestively associated with

296 ous anti-inflammatory lipid mediators (e.g., docosahexaenoic acid) were increased in the conditioned

297 apentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid, were associated with a lower child

298 tty acids, such as eicosapentaenoic acid and docosahexaenoic acid, were released more slowly than oth

299 L was dependent upon the FA dose, except for docosahexaenoic acid, which exhibited binding to CD36 bu

300 ved when we examined the association between docosahexaenoic acid, which is one type of LC n-3 PUFA,